|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2010-5-12
|
|
pubmed:abstractText |
The efficacy and safety of capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer (mCRC) considered unsuitable for receiving first-line chemotherapy with an irinotecan or oxaliplatin-based combination were assessed in a phase II, open, multicentre, uncontrolled study.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-10080589,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-10655437,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-11304782,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-11689577,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-1244564,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-14044222,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-15681523,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-15738537,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-15761078,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-15860870,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-17630036,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-17630037,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-17686822,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-18448553,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-19064978,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-19081732,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-21157451,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-2702835,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-3074322,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20424611-3558716
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1532-1827
|
|
pubmed:author |
pubmed-author:BolañosMM,
pubmed-author:BoschCC,
pubmed-author:Castro-CarpeñoJJ,
pubmed-author:EscuderoPP,
pubmed-author:FeliuJJ,
pubmed-author:García-GirónCC,
pubmed-author:GilMM,
pubmed-author:González-BarónMM,
pubmed-author:LópezRR,
pubmed-author:LlombartAA,
pubmed-author:LoseBB,
pubmed-author:MadroñalCC,
pubmed-author:SafontM JMJ,
pubmed-author:SaltzHH
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
11
|
|
pubmed:volume |
102
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1468-73
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20424611-Aged,
pubmed-meshheading:20424611-Aged, 80 and over,
pubmed-meshheading:20424611-Antibodies, Monoclonal,
pubmed-meshheading:20424611-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:20424611-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20424611-Colorectal Neoplasms,
pubmed-meshheading:20424611-Deoxycytidine,
pubmed-meshheading:20424611-Disease-Free Survival,
pubmed-meshheading:20424611-Female,
pubmed-meshheading:20424611-Fluorouracil,
pubmed-meshheading:20424611-Humans,
pubmed-meshheading:20424611-Kaplan-Meier Estimate,
pubmed-meshheading:20424611-Male
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer.
|
|
pubmed:affiliation |
Medical Oncology Department, Hospital La Paz/Autónoma University School of Medicine. IdiPAZ. RETIC, P degrees de la Castellana, Madrid 261- 28046, Spain. jfeliu.hulp@salud.madrid.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
